Several brokerages have updated their recommendations and price targets on shares of IDEXX Laboratories (NASDAQ: IDXX) in the last few weeks:
- 2/9/2026 – IDEXX Laboratories had its price target lowered by analysts at Piper Sandler from $775.00 to $750.00. They now have a “neutral” rating on the stock.
- 2/7/2026 – IDEXX Laboratories was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
- 2/5/2026 – IDEXX Laboratories had its price target lowered by analysts at Barclays PLC from $850.00 to $800.00. They now have an “overweight” rating on the stock.
- 2/3/2026 – IDEXX Laboratories had its price target lowered by analysts at UBS Group AG from $750.00 to $730.00. They now have a “neutral” rating on the stock.
- 2/3/2026 – IDEXX Laboratories had its price target lowered by analysts at BTIG Research from $830.00 to $800.00. They now have a “buy” rating on the stock.
- 1/29/2026 – IDEXX Laboratories was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating.
- 1/17/2026 – IDEXX Laboratories was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
- 1/12/2026 – IDEXX Laboratories was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating.
- 1/3/2026 – IDEXX Laboratories was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
- 12/29/2025 – IDEXX Laboratories had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
- 12/22/2025 – IDEXX Laboratories was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating.
- 12/15/2025 – IDEXX Laboratories had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
IDEXX Laboratories, Inc (NASDAQ: IDXX) is a global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets. Headquartered in Westbrook, Maine, the company supplies in-clinic diagnostic instruments, consumables, reference laboratory testing and practice-management tools that support veterinarians, livestock and dairy producers, and utilities and food producers worldwide.
IDEXX’s product portfolio includes point-of-care tests and immunoassays designed for rapid diagnosis in veterinary clinics, in-clinic chemistry and hematology analyzers, automated urinalysis systems, and digital diagnostic solutions.
Read More
- Five stocks we like better than IDEXX Laboratories
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Receive News & Ratings for IDEXX Laboratories Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories Inc and related companies with MarketBeat.com's FREE daily email newsletter.
